Moors & Cabot Inc. reduced its holdings in AMETEK, Inc. (NYSE:AME – Free Report) by 2.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,151 shares of the technology company’s stock after selling 462 shares during the period. Moors & Cabot Inc.’s holdings in AMETEK were worth $3,285,000 as of its most recent SEC filing.
Other institutional investors also recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. increased its position in shares of AMETEK by 2.4% during the first quarter. Envestnet Asset Management Inc. now owns 279,473 shares of the technology company’s stock valued at $48,108,000 after purchasing an additional 6,658 shares during the period. TD Private Client Wealth LLC increased its position in shares of AMETEK by 23.4% during the first quarter. TD Private Client Wealth LLC now owns 950 shares of the technology company’s stock valued at $164,000 after purchasing an additional 180 shares during the period. Valeo Financial Advisors LLC bought a new stake in shares of AMETEK during the first quarter valued at approximately $240,000. Flossbach Von Storch SE increased its position in shares of AMETEK by 1.2% during the first quarter. Flossbach Von Storch SE now owns 3,770,066 shares of the technology company’s stock valued at $648,979,000 after purchasing an additional 45,714 shares during the period. Finally, Greenleaf Trust increased its position in shares of AMETEK by 3.2% during the first quarter. Greenleaf Trust now owns 4,183 shares of the technology company’s stock valued at $720,000 after purchasing an additional 131 shares during the period. 87.43% of the stock is owned by institutional investors.
AMETEK Price Performance
AMETEK stock opened at $198.13 on Thursday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.04 and a current ratio of 1.63. The firm has a market cap of $45.76 billion, a P/E ratio of 31.90, a P/E/G ratio of 2.64 and a beta of 1.11. The business’s fifty day moving average is $187.44 and its two-hundred day moving average is $181.58. AMETEK, Inc. has a 52 week low of $145.02 and a 52 week high of $204.15.
AMETEK Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Monday, September 15th were paid a $0.31 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $1.24 dividend on an annualized basis and a yield of 0.6%. AMETEK’s payout ratio is currently 19.56%.
Insider Buying and Selling
In other AMETEK news, insider Ronald J. Oscher sold 26,290 shares of the business’s stock in a transaction on Friday, October 31st. The stock was sold at an average price of $200.05, for a total value of $5,259,314.50. Following the transaction, the insider owned 40,226 shares of the company’s stock, valued at approximately $8,047,211.30. The trade was a 39.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.57% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently issued reports on AME. Royal Bank Of Canada boosted their price objective on AMETEK from $212.00 to $229.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Melius Research upgraded AMETEK to a “hold” rating in a research report on Monday, July 14th. Melius cut AMETEK from a “buy” rating to a “hold” rating and set a $192.00 price target on the stock. in a research report on Monday, July 14th. KeyCorp upped their price target on AMETEK from $205.00 to $220.00 and gave the company an “overweight” rating in a research report on Friday, October 31st. Finally, TD Cowen upgraded AMETEK from a “sell” rating to a “hold” rating and upped their price target for the company from $158.00 to $180.00 in a research report on Tuesday, September 2nd. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $211.00.
Check Out Our Latest Report on AMETEK
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles
- Five stocks we like better than AMETEK
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Why Vertical Aerospace Stock Could Double After This Flight Test
- Comparing and Trading High PE Ratio Stocks
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.
